Trials / Completed
CompletedNCT03793985
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Compare the pharmacokinetic characteristics and safety between CKD-391 tablet and D337, D337 combination
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T | CKD-391 40/10mg |
| DRUG | R | D086 and D337 co-administration |
Timeline
- Start date
- 2018-09-05
- Primary completion
- 2018-10-23
- Completion
- 2018-11-13
- First posted
- 2019-01-04
- Last updated
- 2019-01-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03793985. Inclusion in this directory is not an endorsement.